TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Vaxxinova Norway AS
Closing information (x1000 EUR)
| Closing information | 2023/06 | 2022/06 | 2021/06 |
| Turnover |
1,091
|
1,007
|
836 |
| Financial expenses |
220
|
8
|
30 |
| Earnings before taxes |
-2,275
|
-1,613
|
-2,168 |
| Total assets |
5,303
|
1,992
|
2,900 |
| Current assets |
1,525
|
1,097
|
2,680 |
| Current liabilities |
2,826
|
363
|
300 |
| Equity capital |
1,313
|
54
|
1,326 |
| - share capital |
9
|
10
|
10 |
Financial ratios
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Solvency |
24.8%
|
2.7%
|
45.7% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-208.5%
|
-160.2%
|
-259.3% |
| Return on assets (ROA) |
-38.8%
|
-80.6%
|
-73.7% |
| Current ratio |
54.0%
|
302.2%
|
893.3% |
| Return on equity (ROE) |
-173.3%
|
-2987.0%
|
-163.5% |
| Change turnover |
198
|
185
|
-2,753 |
| Change turnover % |
22%
|
23%
|
-77% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.